Abacus Global Boosts 2026 Guidance on Longevity Fund Surge
Event summary
- Abacus raised full-year 2026 adjusted net income guidance to $100–$106 million, up 24% YoY.
- Longevity Income Funds AUM grew nearly 4x YoY to approximately $1 billion.
- Operating cash flow surged to $91.7 million, a $153 million YoY increase.
- Abacus agreed to acquire a $53 million minority stake in Manning & Napier.
- Adjusted EBITDA grew 33.3% YoY to $32.7 million.
The big picture
Abacus' strong Q1 2026 results highlight the growing institutional appetite for longevity-based assets, which are structurally uncorrelated to traditional market cycles. The company's strategic investments in Manning & Napier and its second securitization signal a push to diversify revenue streams while maintaining high-margin operations. With AUM approaching $3.6 billion and operating cash flow demonstrating significant scalability, Abacus is positioning itself as a key player in the alternative asset management space.
What we're watching
- Longevity Demand
- Whether institutional demand for mortality-driven assets will sustain Abacus' growth trajectory.
- Integration Risk
- How the Manning & Napier acquisition will impact Abacus' operational efficiency and product distribution.
- Guidance Credibility
- The pace at which Abacus can deliver on its raised 2026 financial targets.
Related topics